Nilotinib(25 mg) 4-Methyl-N-[3-(4-methyl-1H-imidazol-1-yl)- 5-(trifluoromethyl)phenyl]-3- [(4-pyridin-3-ylpyrimidin-2-yl) amino]benzamide BioVision 1750-25 1440/25 mg 详情
Nilotinib(100 mg) 4-methyl-N-[3-(4-methyl-1H-imidazol-1-yl)- 5-(trifluoromethyl)phenyl]-3- [(4-pyridin-3-ylpyrimidin-2-yl) amino]benzamide BioVision 1750-100 4230/100 mg 详情
Epirubicin Hydrochloride(5 mg) (8S-cis)-10-((3-amino-2,3,6-trideoxy-β-L-arabino-hexopyranosyl)oxy-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-5,12-naphthacenedione hydrochloride; 4'-epiadriamycin; 4'-epidoxorubicin BioVision 1753-5 1800/5 mg 详情
Vandetanib(25 mg) N-(4-Bromo-2-fluorophenyl)-6-methoxy-7-((1-methylpiperidin-4-yl)methoxy)quinazolin-4-amine; ZD6474, Zactima BioVision 1751-25 1800/25 mg 详情
Vandetanib(100 mg) N-(4-Bromo-2-fluorophenyl)-6-methoxy-7-((1-methylpiperidin-4-yl)methoxy)quinazolin-4-amine; ZD6474, Zactima BioVision 1751-100 5400/100 mg 详情
Irinotecan Hydrochloride(50 mg) S)-4,11-diethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo1H-pyrano[3’,4’:6,7]-indolizino[1,2-b]quinolin-9-yl-[1,4’bipiperidine]-1’-carboxylate, Hydrochloride BioVision 1752-50 1440/50 mg 详情
Irinotecan Hydrochloride(250 mg) S)-4,11-diethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo1H-pyrano[3’,4’:6,7]-indolizino[1,2-b]quinolin-9-yl-[1,4’bipiperidine]-1’-carboxylate, Hydrochloride BioVision 1752-250 5400/250 mg 详情
Teicoplanin(100 mg) Teichomycin BioVision 1756-100 1080/100 mg 详情
Teicoplanin(1 g) Teichomycin BioVision 1756-1G 7470/1 g 详情
Sitagliptin Phosphate Monohydrate(100 mg) 7-[(3R)-3-amino-1-oxo-4-(2,4,5-trifluorophenyl)butyl]-5,6,7,8-tetrahydro-3-(trifluoromethyl)-1,2,4-triazolo[4,3-a]pyrazine phosphate; MK-0431 BioVision 1757-100 1260/100 mg 详情
Sitagliptin Phosphate Monohydrate(1 g) 7-[(3R)-3-amino-1-oxo-4-(2,4,5-trifluorophenyl)butyl]-5,6,7,8-tetrahydro-3-(trifluoromethyl)-1,2,4-triazolo[4,3-a]pyrazine phosphate; MK-0432 BioVision 1757-1G 7470/1 g 详情
Resveratrol(100 mg) 3,4′,5-Trihydroxy-trans-stilbene, 5-[(1E)-2-(4-Hydroxyphenyl)ethenyl]-1,3-benzenediol BioVision 1758-100 1080/100 mg 详情
Resveratrol(500 mg) 3,4′,5-Trihydroxy-trans-stilbene, 5-[(1E)-2-(4-Hydroxyphenyl)ethenyl]-1,3-benzenediol BioVision 1758-500 3870/500 mg 详情
Gemcitabine Hydrochloride(25 mg) 2′,2′-difluoro-2′-deoxycytidine; Gamcitabine; Gemcitera; Gemsar; Gemzar; LY-188011 BioVision 1759-25 1620/25 mg 详情
Gemcitabine Hydrochloride(100 mg) 2′,2′-difluoro-2′-deoxycytidine; Gamcitabine; Gemcitera; Gemsar; Gemzar; LY-188012 BioVision 1759-100 5130/100 mg 详情
Nafamostat Mesylate(10 mg) 4-[(Aminoiminomethyl)amino]benzoic acid 6-(aminoiminomethyl)-2-naphthalenyl ester dimethanesulfonate; FUT-175; Futhan BioVision 1760-10 1260/10 mg 详情
Nafamostat Mesylate(50 mg) 4-[(Aminoiminomethyl)amino]benzoic acid 6-(aminoiminomethyl)-2-naphthalenyl ester dimethanesulfonate; FUT-175; Futhan BioVision 1760-50 4860/50 mg 详情
Triptolide(1 mg) TPL BioVision 1761-1 1260/1 mg 详情
Triptolide(5 mg) TPL BioVision 1761-5 4950/5 mg 详情
Honokiol(10 mg) 2-(4-hydroxy-3-prop-2-enyl-phenyl)- 4-prop-2-enyl-phenol; HNK; Houpa BioVision 1762-10 1260/10 mg 详情
Honokiol(50 mg) 2-(4-hydroxy-3-prop-2-enyl-phenyl)- 4-prop-2-enyl-phenol; HNK; Houpa BioVision 1762-50 4950/50 mg 详情
Fludarabine Phosphate(10 mg) [(2R,3R,4S,5R)-5-(6-amino-2-fluoro-purin-9-yl)- 3,4-dihydroxy-oxolan-2-yl]methoxyphosphonic acid; Fludara BioVision 1763-10 1440/10 mg 详情
Fludarabine Phosphate(50 mg) [(2R,3R,4S,5R)-5-(6-amino-2-fluoro-purin-9-yl)- 3,4-dihydroxy-oxolan-2-yl]methoxyphosphonic acid; Fludara BioVision 1763-50 5580/50 mg 详情
Okadaic acid, Sodium Salt(25 ug) Halochondrine A, Sodium Salt; OA BioVision 1764-025 1890/25 ug 详情
Okadaic acid, Potassium Salt(25 ug) Halochondrine A, Potassium Salt; OA BioVision 1765-025 1890/25 ug 详情
Okadaic acid, Ammonium Salt(25 ug) Halochondrine A, Ammonium Salt; OA BioVision 1766-025 1890/25 ug 详情
PP2(1 mg) 1-tert-Butyl-3-(4-chlorophenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine BioVision 1767-1 1800/1 mg 详情
PP2(5 mg) 1-tert-Butyl-3-(4-chlorophenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine BioVision 1767-5 6930/5 mg 详情
H-89 Dihydrochloride(1 mg) N-[2-[[3-(4-Bromophenyl)-2-propen-1-yl]amino]ethyl]-5-Isoquinolinesulfonamide dihydrochloride BioVision 1768-1 1710/1 mg 详情
H-89 Dihydrochloride(5 mg) N-[2-[[3-(4-Bromophenyl)-2-propen-1-yl]amino]ethyl]-5-Isoquinolinesulfonamide dihydrochloride BioVision 1768-5 6660/5 mg 详情
SB 216763(1 mg) 3-(2,4-Dichlorophenyl)-4-(1-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione BioVision 1769-1 1530/1 mg 详情
SB 216763(5 mg) 3-(2,4-Dichlorophenyl)-4-(1-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione BioVision 1769-5 5580/5 mg 详情
D4476(1 mg) 4-[4-(2,3-Dihydro-1,4-benzodioxin-6-yl)-5-(2-pyridinyl) -1H-imidazol-2-yl]benzamide BioVision 1770-1 1440/1 mg 详情
D4476(5 mg) 4-[4-(2,3-Dihydro-1,4-benzodioxin-6-yl)-5-(2-pyridinyl) -1H-imidazol-2-yl]benzamide BioVision 1770-5 5580/5 mg 详情
DR2313(1 mg) 1,5,7,8-Tetrahydro-2-methyl-4H-thiopyrano[4,3-d]pyrimid in-4-one BioVision 1771-1 1260/1 mg 详情
DR2313(5 mg) 1,5,7,8-Tetrahydro-2-methyl-4H-thiopyrano[4,3-d]pyrimid in-4-one BioVision 1771-5 5130/5 mg 详情
17-AAG(1 mg) Telatinib; 17-(Allylamino)-17-demethoxygeldanamycin; 17-(Allylamino)geldanamycin; Tanespimycin BioVision 1774-1 2340/1 mg 详情
17-AAG(5 mg) Telatinib; 17-(Allylamino)-17-demethoxygeldanamycin; 17-(Allylamino)geldanamycin; Tanespimycin BioVision 1774-5 8910/5 mg 详情
Stat3抑制剂I, S3I-201(5 mg) 2-Hydroxy-4-[[[[4-methylphenyl)sulfonyl]oxy]acetyl]amino]-benzoic acid; NSC 74859; S3I-201 BioVision 1775-5 1620/5 mg 详情
Stat3抑制剂I, S3I-201(25 mg) 2-Hydroxy-4-[[[[4-methylphenyl)sulfonyl]oxy]acetyl]amino]-benzoic acid; NSC 74859; S3I-202 BioVision 1775-25 6390/25 mg 详情
17-DMAG hydrochloride(1 mg) 17-(Dimethylaminoethylamino)-17-demethoxygeldanamycin Hydrochloride; Alvespimycin BioVision 1776-1 2340/1 mg 详情
17-DMAG hydrochloride(5 mg) 17-(Dimethylaminoethylamino)-17-demethoxygeldanamycin Hydrochloride; Alvespimycin BioVision 1776-5 8910/5 mg 详情
Sulfobetaine 3-16(5 g) n-Hexadecyl-N,N-dimethyl-3-ammonio-1-propanesulfonate; SB3-16 BioVision 1777-5G 1620/5 g 详情
Sulfobetaine 3-16(25 g) n-Hexadecyl-N,N-dimethyl-3-ammonio-1-propanesulfonate; SB3-16 BioVision 1777-25G 6120/25 g 详情
Stat3 Peptide Inhibitor, Cell-Permeable(1 mg) PY*LKTK-mts (where Y* = phosphotyrosine) BioVision 1778-1 2970/1 mg 详情
Stat3 Peptide Inhibitor, Cell-Permeable(5 mg) PY*LKTK-mts (where Y* = phosphotyrosine) BioVision 1778-5 11790/5 mg 详情
mTOR Inhibitor, Ku-0063794(1 mg) rel-5-[2-[(2R,6S)-2,6-Dimethyl-4-morpholinyl]-4-(4-morpholinyl)pyrido[2,3-d]pyrimidin-7-yl]-2-methoxybenzenemethanol BioVision 1779-1 1620/1 mg 详情
mTOR Inhibitor, Ku-0063794(5 mg) rel-5-[2-[(2R,6S)-2,6-Dimethyl-4-morpholinyl]-4-(4-morpholinyl)pyrido[2,3-d]pyrimidin-7-yl]-2-methoxybenzenemethanol BioVision 1779-5 6120/5 mg 详情
PI3-K 5-(6-Quinoxalinylmethylene)-2,4-thiazolidine-2,4-dione BioVision 1780-1 1350/1 mg 详情
PI3-K 5-(6-Quinoxalinylmethylene)-2,4-thiazolidine-2,4-dione BioVision 1780-5 4860/5 mg 详情
首页 公司简介 新闻中心 产品中心 特色产品 技术专栏 在线订购 联系我们

版权所有 艾美捷科技有限公司

地址:武汉市洪山区光谷大道35号光谷总部国际二期时代1栋13楼 邮政编码:430074

电话:+86-027-59626688 全国免费技术支持: 400-6800-868 传真:+86-027-59716800

鄂ICP备10204150号